IDH1 and glioblastoma: IDH2 mutation at R172 (R172K) residue is found only in 3% of WHO grade-II and -III astrocytomas, oligodendrogliomas, and secondary glioblastomas, whereas IDH1 mutation at R132 (R132H) affects 70% of these cancers [36].